TWO SIGMA ADVISERS, LP - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 116 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$139,191
-64.7%
107,900
-53.0%
0.00%
-100.0%
Q2 2023$394,568
-49.4%
229,400
-55.6%
0.00%
-50.0%
Q1 2023$779,311
-7.2%
516,100
-1.7%
0.00%0.0%
Q4 2022$839,840
+9.8%
524,900
-0.5%
0.00%0.0%
Q3 2022$765,000
+8.1%
527,400
+36.3%
0.00%0.0%
Q2 2022$708,000
-23.9%
387,000
+11.1%
0.00%0.0%
Q1 2022$930,000
+6.5%
348,300
+72.8%
0.00%0.0%
Q4 2021$873,000
-14.7%
201,600
+0.2%
0.00%
-33.3%
Q3 2021$1,024,000
-56.2%
201,200
-45.5%
0.00%
-50.0%
Q2 2021$2,336,000
-53.6%
369,100
-43.3%
0.01%
-57.1%
Q1 2021$5,031,000
+10.9%
650,900
-6.1%
0.01%
+16.7%
Q4 2020$4,538,000
+23.1%
692,900
+25.0%
0.01%
+9.1%
Q3 2020$3,685,000
-18.3%
554,100
+2.3%
0.01%
-15.4%
Q2 2020$4,513,000
+20.6%
541,800
+11.1%
0.01%
-7.1%
Q1 2020$3,741,000
-6.2%
487,700
+1.6%
0.01%
+55.6%
Q4 2019$3,990,000
+130.1%
480,100
+104.4%
0.01%
+125.0%
Q3 2019$1,734,000
-39.0%
234,900
-7.2%
0.00%
-42.9%
Q2 2019$2,841,000
+5.3%
253,200
+0.8%
0.01%0.0%
Q1 2019$2,699,000
-29.7%
251,100
-1.2%
0.01%
-30.0%
Q4 2018$3,837,000
-21.7%
254,100
-4.1%
0.01%
-16.7%
Q3 2018$4,901,000
-21.8%
264,900
-3.4%
0.01%
-29.4%
Q2 2018$6,266,000
+16.7%
274,100
+45.2%
0.02%
+13.3%
Q1 2018$5,371,000
+108.3%
188,800
+54.6%
0.02%
+114.3%
Q4 2017$2,578,000
+168.3%
122,100
+130.8%
0.01%
+133.3%
Q3 2017$961,00052,9000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders